Kevin McCaffrey

Most Recent Articles by Kevin McCaffrey

Five things for pharma marketers to know: Thursday, August 25, 2016

Five things for pharma marketers to know: Thursday, August 25, 2016

Mylan offers additional copay assistance for EpiPen amid criticism; fewer doctors are seeing reps; two Copaxone patents are invalidated

Shire taps Jennifer Aniston for awareness campaign as it enters the eye care market

Shire taps Jennifer Aniston for awareness campaign as it enters the eye care market

The drugmaker expects the multi-channel initiative to lay its foundation in the ophthalmology market.

Five things for pharma marketers to know: Tuesday, August 23, 2016

Five things for pharma marketers to know: Tuesday, August 23, 2016

Grassley blasts Mylan over EpiPen price increases; Portola Pharmaceuticals receives CRL letter for reversal agent; the FDA approves Pfizer's opioid

In Medivation deal, Pfizer will gain an oncology blockbuster

In Medivation deal, Pfizer will gain an oncology blockbuster

Pfizer's commercial expertise in urology and oncology could help propel Medivation's Xtandi to new heights.

Five things for pharma marketers to know: Wednesday, August 17, 2016

Five things for pharma marketers to know: Wednesday, August 17, 2016

AHIP study says half of orphan-drug usage is for non-orphan indications; Studies of GSK weight-loss pill underestimated side effects; ViiV starts HIV trial

More Articles by Kevin McCaffrey

OPINION

Email Newsletters